MedPath

prevention of drug addictio

Phase 2
Conditions
addiction.
Mental and behavioural disorders due to psychoactive substance use
F10, F11,
Registration Number
IRCT2016062528588N1
Lead Sponsor
Vice chancellor for research of Baqiatallah University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
66
Inclusion Criteria

male; Earn a high score in the Addiction Potential Scale (score above 21) and Alexithymia Scale (higher the total score of 60); agreement to participate in research according to informed consent.
Exclusion criteria: psychotic symptoms; A history of drug abuse or drug dependence in current or past; Existence of suicidal thoughts and depression; At the same time receive psychiatric treatment or psychotherapy.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Addiction potential. Timepoint: before the intervention (pre-test), immediately after the intervention (post-test), after one month of the intervention (follow-up),. Method of measurement: Zargar Addiction Potential questionnaires.;Alexithymia. Timepoint: before the intervention (pre-test), immediately after the intervention (post-test), after one month of the intervention (follow-up),. Method of measurement: based on Toronto Alexithymia questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath